Setback for Medtronic in ongoing patent dispute with Johnson & Johnson
This article was originally published in Clinica
Executive Summary
The US Supreme Court refused to hear Medtronic's appeal over a patent infringement ruling in favour of Johnson & Johnson on February 23. At stake is $271.1m in damages that, as it stands, Medtronic is required to pay to its rival. However, the Supreme Court's decision does not conclude the dispute, and the case is to be reviewed in a district court next month.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.